Mondher Mahjoubi, MD, joined AstraZeneca in 2013 to lead the oncology therapy area within Global Product and Portfolio Strategy (GPPS). He is part of the GPPS leadership team and is based in Gaithersburg, US.

Mondher brings a wealth of experience in the field of oncology to AstraZeneca, having held senior positions in the pharmaceutical and biotechnology industry for over 23 years. Most recently he was the Senior Vice-President global product strategy in oncology at Genentech, based in San Francisco, where he was responsible for shaping the oncology portfolio and providing strategic business direction from research through to development, commercialisation and medical excellence.

Mondher has also held various senior global and affiliate-based positions in marketing and medical affairs for pharmaceutical companies including Mayne Pharma, Sanofi-Aventis, and Rhone Poulenc Rorer based in London, New Jersey and Paris respectively.

He holds a doctorate in Medicine and a certification in Medical Oncology and Clinical Research, and is trained as a medical oncologist. He is a member of the American Society of Clinical Oncology and European Society of Medical Oncology.

It’s all about the patients, that’s what truly inspires me every day and our ambition at AstraZeneca is to deliver innovative cancer treatments that will transform the patient journey and improve life.

Mondher Mahjoubi